Tango Biosciences, Inc.
Publicly observedChicago, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Chicago | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Tango Biosciences, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | RDG9AVNDS6N5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Apr 2026Publicly observed
NIH SBIR/STTR award: Peptide Glues
USD 332,917.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2025Publicly observed
NIH SBIR/STTR award: The Avidimer Platform - a molecular toolbox to accelerate proximity research and drug discovery
USD 314,363.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2022Publicly observed
NIH SBIR/STTR award: Generating phosphobodies to activated protein kinases
USD 1,150,462.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.